News

3M Files With SEC for Healthcare Spin Off

3M has officially filed a Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its healthcare business as the newly independent healthcare company Solventum.

Pending final approval from 3M’s board of directors, Solventum is slated to spin off April 1. The new company has applied to list on the New York Stock Exchange as “SOLV.” According to the filings, Solventum had sales of US$8.2 billion in 2023 and will include more than 20,000 employees led by Bryan Hanson as CEO, Wayde McMillan as chief financial officer, and Carrie Cox as board chair.

About 3M
With global sales of US$32.7 billion, 3M is a leading producer of thousands of products ranging from chemicals, filtration systems, and safety and protection equipment to office, graphics, and healthcare equipment. For more information, visit 3M.com.